APA
Laufersweiler M. J., Brugel T. A., Clark M. P., Golebiowski A., Bookland R. G., Laughlin S. K., Sabat M. P., Townes J. A., VanRens J. C., De B., Hsieh L. C., Heitmeyer S. A., Juergens K., Brown K. K., Mekel M. J., Walter R. L. & Janusz M. J. (20050223). The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones. : Bioorganic & medicinal chemistry letters.
Chicago
Laufersweiler Matthew J, Brugel Todd A, Clark Michael P, Golebiowski Adam, Bookland Roger G, Laughlin Steven K, Sabat Mark P, Townes Jennifer A, VanRens John C, De Biswanath, Hsieh Lily C, Heitmeyer Sandra A, Juergens Karen, Brown Kimberly K, Mekel Marlene J, Walter Richard L and Janusz Michael J. 20050223. The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones. : Bioorganic & medicinal chemistry letters.
Harvard
Laufersweiler M. J., Brugel T. A., Clark M. P., Golebiowski A., Bookland R. G., Laughlin S. K., Sabat M. P., Townes J. A., VanRens J. C., De B., Hsieh L. C., Heitmeyer S. A., Juergens K., Brown K. K., Mekel M. J., Walter R. L. and Janusz M. J. (20050223). The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones. : Bioorganic & medicinal chemistry letters.
MLA
Laufersweiler Matthew J, Brugel Todd A, Clark Michael P, Golebiowski Adam, Bookland Roger G, Laughlin Steven K, Sabat Mark P, Townes Jennifer A, VanRens John C, De Biswanath, Hsieh Lily C, Heitmeyer Sandra A, Juergens Karen, Brown Kimberly K, Mekel Marlene J, Walter Richard L and Janusz Michael J. The development of novel inhibitors of tumor necrosis factor-alpha (TNF-alpha) production based on substituted [5,5]-bicyclic pyrazolones. : Bioorganic & medicinal chemistry letters. 20050223.